Phase I study of ursodeoxycholic acid in combination with 5-fluorouracil, leucovorin, oxaliplatin, and bevacizumab for metastatic colorectal cancer

被引：0
|
作者：
Lai, Lily L.
Chiu, Ken
Lim, Dean
Chao, Joseph
Frankel, Paul Henry
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Hope Canc Ctr, Beckman Res Inst, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
569
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of 5-fluorouracil, leucovorin and bevacizumab in combination with radiation therapy in patients with locally advanced rectal cancer
    Inoue, Yasuhiro
    Okigami, Masato
    Kawamoto, Aya
    Okugawa, Yoshinaga
    Hiro, Junichiro
    Saigusa, Susumu
    Toiyama, Yuji
    Tanaka, Koji
    Mohri, Yasuhiko
    Kusunoki, Masato
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 511 - 516
  • [32] Paclitaxel, oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in patients with recurrent or metastatic gastric cancer
    Lan, Yan-qin
    Wu, Ri-ping
    Huang, Xiao-bing
    Wang, Xin-li
    Zhong, Dong-ta
    Huang, Chuan-yong
    Song, Jin-tian
    TUMORI JOURNAL, 2018, 104 (01): : 22 - 29
  • [33] A phase I study of 5-fluorouracil, leucovorin, and celecoxib in patients with incurable colorectal cancer
    Blanke, CD
    Mattek, NC
    Deloughery, TG
    Koop, DR
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2005, 75 (1-4) : 169 - 172
  • [34] Health-Related Quality of Life Impact of Bevacizumab When Combined with Irinotecan, 5-Fluorouracil, and Leucovorin or 5-Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
    Kabbinavar, Fairooz F.
    Wallace, Joel F.
    Holmgren, Eric
    Yi, Jing
    Cella, David
    Yost, Kathleen J.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2008, 13 (09): : 1021 - 1029
  • [35] A multicenter phase 2 clinical trial testing a combination of oxaliplatin, bolus 5-fluorouracil, leucovorin and capecitabine in patients with metastatic colorectal cancer (MCRC)
    LoConte, N. K.
    Holen, K. D.
    Eickhoff, J.
    Dzelak, T.
    Richie, K.
    Teeter, K.
    Warren, D.
    Jumonville, A. J.
    Kwong, R. W.
    Mulkerin, D. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Phase I/II study of irinotecan, 5-fluorouracil, and I-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer
    Goto A.
    Yamada Y.
    Hosokawa A.
    Ura T.
    Arai T.
    Hamaguchi T.
    Muro K.
    Shimada Y.
    Shirao K.
    International Journal of Clinical Oncology, 2004, 9 (5) : 364 - 368
  • [37] Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer
    Kono, T
    Ebisawa, Y
    Tomita, I
    Chisato, N
    Kamiya, K
    Asama, T
    Ayabe, T
    Ashida, T
    Kohgo, Y
    Kasai, S
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 224 - 227
  • [38] A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer
    Yamaguchi, Y
    Minami, K
    Kawabuchi, Y
    Emi, M
    HEPATO-GASTROENTEROLOGY, 2006, 53 (68) : 201 - 205
  • [39] Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
    Buchler, Tomas
    Pavlik, Tomas
    Melichar, Bohuslav
    Bortlicek, Zbynek
    Usiakova, Zuzana
    Dusek, Ladislav
    Kiss, Igor
    Kohoutek, Milan
    Benesova, Vera
    Vyzula, Rostislav
    Abrahamova, Jitka
    Obermannova, Radka
    BMC CANCER, 2014, 14
  • [40] Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
    Tomas Buchler
    Tomas Pavlik
    Bohuslav Melichar
    Zbynek Bortlicek
    Zuzana Usiakova
    Ladislav Dusek
    Igor Kiss
    Milan Kohoutek
    Vera Benesova
    Rostislav Vyzula
    Jitka Abrahamova
    Radka Obermannova
    BMC Cancer, 14
12345